In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
October 6th, 2004 | 18 | No |
Popular Name: beta-Lapachone beta-Lapachone
Find On: PubMed — Wikipedia — Google
CAS Number: 4707-32-8
2,2-Dimethyl-3,4-dihydro-2H-benzo[h]chromene-5,6-dione
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 2.95 | 8.03 | -10.63 | 0 | 3 | 0 | 43 | 242.274 | 0 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
Target | Topoisomerase | Selleck Chemicals |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
KD4DL-1-E | Lysine-specific Demethylase 4D-like (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3550 | 0.42 | Binding ≤ 10μM |
Z101879-1-O | Leptomonas Seymouri (cluster #1 Of 1), Other | Other | 400 | 0.50 | Functional ≤ 10μM |
Z50425-3-O | Plasmodium Falciparum (cluster #3 Of 22), Other | Other | 6310 | 0.40 | Functional ≤ 10μM |
Z50466-5-O | Trypanosoma Cruzi (cluster #5 Of 8), Other | Other | 210 | 0.52 | Functional ≤ 10μM |
Z80002-2-O | 1A9 (Ovarian Adenocarcinoma Cells) (cluster #2 Of 2), Other | Other | 800 | 0.47 | Functional ≤ 10μM |
Z80125-1-O | DU-145 (Prostate Carcinoma) (cluster #1 Of 9), Other | Other | 7 | 0.63 | Functional ≤ 10μM |
Z80156-2-O | HL-60 (Promyeloblast Leukemia Cells) (cluster #2 Of 12), Other | Other | 1650 | 0.45 | Functional ≤ 10μM |
Z80224-1-O | MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other | Other | 9960 | 0.39 | Functional ≤ 10μM |
Z80390-1-O | PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other | Other | 1130 | 0.46 | Functional ≤ 10μM |
Z80682-1-O | A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other | Other | 4210 | 0.42 | Functional ≤ 10μM |
Z80980-1-O | HOS (Osteosarcoma Cells) (cluster #1 Of 2), Other | Other | 1400 | 0.46 | Functional ≤ 10μM |
Z81115-2-O | KB (Squamous Cell Carcinoma) (cluster #2 Of 6), Other | Other | 1800 | 0.45 | Functional ≤ 10μM |
Z81245-1-O | MDA-MB-435 (Breast Carcinoma Cells) (cluster #1 Of 6), Other | Other | 250 | 0.51 | Functional ≤ 10μM |
Z100081-1-O | PBMC (Peripheral Blood Mononuclear Cells) (cluster #1 Of 2), Other | Other | 2100 | 0.44 | ADME/T ≤ 10μM |
Z80156-4-O | HL-60 (Promyeloblast Leukemia Cells) (cluster #4 Of 4), Other | Other | 270 | 0.51 | ADME/T ≤ 10μM |
Z80901-1-O | HaCaT (Keratinocytes) (cluster #1 Of 2), Other | Other | 700 | 0.48 | ADME/T ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
KD4DL_HUMAN | B2RXH2 | Lysine-specific Demethylase 4D-like, Human | 3000 | 0.43 | Binding ≤ 10μM |
Z80002 | Z80002 | 1A9 (Ovarian Adenocarcinoma Cells) | 800 | 0.47 | Functional ≤ 10μM |
Z80682 | Z80682 | A549 (Lung Carcinoma Cells) | 1500 | 0.45 | Functional ≤ 10μM |
Z80125 | Z80125 | DU-145 (Prostate Carcinoma) | 7.4 | 0.63 | Functional ≤ 10μM |
Z80156 | Z80156 | HL-60 (Promyeloblast Leukemia Cells) | 1650 | 0.45 | Functional ≤ 10μM |
Z80980 | Z80980 | HOS (Osteosarcoma Cells) | 1400 | 0.46 | Functional ≤ 10μM |
Z81115 | Z81115 | KB (Squamous Cell Carcinoma) | 1000 | 0.47 | Functional ≤ 10μM |
Z101879 | Z101879 | Leptomonas Seymouri | 400 | 0.50 | Functional ≤ 10μM |
Z80224 | Z80224 | MCF7 (Breast Carcinoma Cells) | 800 | 0.47 | Functional ≤ 10μM |
Z81245 | Z81245 | MDA-MB-435 (Breast Carcinoma Cells) | 250 | 0.51 | Functional ≤ 10μM |
Z80390 | Z80390 | PC-3 (Prostate Carcinoma Cells) | 1130 | 0.46 | Functional ≤ 10μM |
Z50425 | Z50425 | Plasmodium Falciparum | 3981.07171 | 0.42 | Functional ≤ 10μM |
Z50466 | Z50466 | Trypanosoma Cruzi | 210 | 0.52 | Functional ≤ 10μM |
Z80901 | Z80901 | HaCaT (Keratinocytes) | 700 | 0.48 | ADME/T ≤ 10μM |
Z80156 | Z80156 | HL-60 (Promyeloblast Leukemia Cells) | 270 | 0.51 | ADME/T ≤ 10μM |
Z100081 | Z100081 | PBMC (Peripheral Blood Mononuclear Cells) | 2100 | 0.44 | ADME/T ≤ 10μM |